Colorectal Cancer Screening

American Journal of Lifestyle Medicine

Volumn 6, Issue 3, 2012, Pages 196-203

  Diaz, Joseph A ^a,b   Slomka, Teresa ^b  

^a BROWN UNIVERSITY   (United States)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

colorectal cancer; recommendation guidelines; screening

Indexed keywords

EID: 84860512931     PISSN: 15598276     EISSN: 15598284     Source Type: Journal    
DOI: 10.1177/1559827611413243     Document Type: Review

References (55)

1. American Cancer Society. Colorectal Cancer Facts & Figures 2011-2013. Atlanta, GA: American Cancer Society; 2011. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-028323.pdf. Accessed June 21, 2011.
2. American Cancer Society. Facts & Figures 2011. Atlanta, GA: American Cancer Society; 2011. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-028323.pdf.Accessed June 21, 2011.
3. Selby JV,Friedman GD,Quesenberry CP,Weiss NS.A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.N Engl J Med. 1992;326:653-657.
4. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2008;149:627-637.
5. Burt RW.Colon cancer screening.Gastroenterology. 2000;119:837-853.
6. Vital signs: colorectal cancer screening among adults aged 50-75 years-United States, 2008.MMWR Morb Mortal Wkly Rep. 2010;59:808-812.
7. Levine JS,Ahnen DJ.Clinical practice. Adenomatous polyps of the colon.N Engl J Med. 2006;355:2551-2557.
8. Mandel JS,Bond JH,Church TR, et al.Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.N Engl J Med. 1993;328:1365-1371.
9. Hardcastle JD,Chamberlain JO,Robinson MH, et al.Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.Lancet. 1996;348:1472-1477.
10. Kronborg O,Fenger C,Olsen J,Jorgensen OD,Sondergaard O.Randomised study of screening for colorectal cancer with faecal-occult-blood test.Lancet. 1996;348:1467-1471.
11. Hundt S,Haug U,Brenner H.Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.Ann Intern Med. 2009;150:162-169.
12. Levin B,Lieberman D,McFarland B, et al.Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.CA Cancer J Clin. 2008;58:130-160.
13. Allison JE,Sakoda LC,Levin TR, et al.Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.J Natl Cancer Inst. 2007;99:1462-1470.
14. Walsh JM,Terdiman JP.Colorectal cancer screening: scientific review.JAMA. 2003;289:1288-1296.
15. Nadel MR,Shapiro JA,Klabunde CN, et al.A national survey of primary care physicians' methods for screening for fecal occult blood.Ann Intern Med. 2005;142:86-94.
16. Ahlquist DA,Sargent DJ,Loprinzi CL, et al.Stool DNA and occult blood testing for screen detection of colorectal neoplasia.Ann Intern Med. 2008;149:441-450.
17. Johnson CD,Chen MH,Toledano AY, et al.Accuracy of CT colonography for detection of large adenomas and cancers.N Engl J Med. 2008;359:1207-1217.
18. Pickhardt PJ,Choi JR,Hwang I, et al.Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.N Engl J Med. 2003;349:2191-2200.
19. Kim DH,Pickhardt PJ,Taylor AJ, et al.CT colonography versus colonoscopy for the detection of advanced neoplasia.N Engl J Med. 2007;357:1403-1412.
20. Whitlock E,Lin J,Liles E, et alScreening for Colorectal Cancer: An Updated Systematic Review. Evidence Synthesis No. 65, Part 1. Rockville, MD: Agency for Healthcare Research and Quality; 2008:.
21. Winawer SJ,Zauber AG,Ho MN, et al.Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.N Engl J Med. 1993;329:1977-1981.
22. Citarda F,Tomaselli G,Capocaccia R,Barcherini S,Crespi M.Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.Gut. 2001;48:812-815.
23. Meissner HI,Breen N,Klabunde CN,Vernon SW.Patterns of colorectal cancer screening uptake among men and women in the United States.Cancer Epidemiol Biomarkers Prev. 2006;15:389-394.
24. Gross CP,Andersen MS,Krumholz HM,McAvay GJ,Proctor D,Tinetti ME.Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.JAMA. 2006;296:2815-2822.
25. Ransohoff DF.How much does colonoscopy reduce colon cancer mortality?.Ann Intern Med. 2009;150:50-52.
26. Baxter NN,Goldwasser MA,Paszat LF,Saskin R,Urbach DR,Rabeneck L.Association of colonoscopy and death from colorectal cancer.Ann Intern Med. 2009;150:1-8.
27. Whitlock EP,Lin JS,Liles E,Beil TL,Fu R.Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.Ann Intern Med. 2008;149:638-658.
28. Rex DK,Johnson DA,Anderson JC,Schoenfeld PS,Burke CA,Inadomi JM.American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].Am J Gastroenterol. 2009;104:739-750.
29. Use of colorectal cancer tests-United States, 2002, 2004, and 2006.MMWR Morb Mortal Wkly Rep. 2008;57:253-258.
30. Agency for Healthcare Research and Quality. National Healthcare Disparities Report2008. http://www.ahrq.gov/qual/nhdr08/nhdr08.pdf.Accessed September 14, 2010.
31. Chien C,Morimoto LM,Tom J,Li CI.Differences in colorectal carcinoma stage and survival by race and ethnicity.Cancer. 2005;104:629-639.
32. Steinwachs D,Allen JD,Barlow WE, et al.National Institutes of Health state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med; 2010; 2010. 663.
33. Walsh JM,Kaplan CP,Nguyen B,Gildengorin G,McPhee SJ,Pérez-Stable EJ.Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans.J Gen Intern Med. 2004;19:156-166.
34. Goldman RE,Diaz J,Kim I.Perspectives of colorectal cancer risk and screening among Dominicans and Puerto Ricans: stigma and misperceptions.Qual Health Res. 2009;19:1559-1568.
35. Diaz JA,Goldman R,Arellano N,Borkan J,Eaton CB.Brief report: exploration of colorectal cancer risk perceptions among Latinos.J Immigr Minor Health. 2011;13:188-192.
36. Diaz JA,Roberts MB,Goldman RE,Weitzen S,Eaton CB.Effect of language on colorectal cancer screening among Latinos and non-Latinos.Cancer Epidemiol Biomarkers Prev. 2008;17:2169-2173.
37. Laiyemo AO,Doubeni C,Pinsky PF, et al.Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities.J Natl Cancer Inst. 2010;102:538-546.
38. New York City Department of Health and Mental Hygiene. Colon cancer. http://www.nyc.gov/html/doh/html/cancer/cancercolon.shtml.
39. Seeff LC,Major A,Townsend JS, et al.Comprehensive cancer control programs and coalitions: partnering to launch successful colorectal cancer screening initiatives.Cancer Causes Control. 2010;21:2023-2031.
40. Winawer S,Fletcher R,Rex D, et al.Colorectal cancer screening and surveillance: clinical guidelines and rationale: update based on new evidence.Gastroenterology. 2003;124:544-560.
41. Zauber AG,Lansdorp-Vogelaar I,Knudsen AB,Wilschut J,van Ballegooijen M,Kuntz KM.Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.Ann Intern Med. 2008;149:659-669.
42. Zauber AG,Lansdrop-Vogelaar I,Knudsen AB,Wilschut J,Van Ballegooijen M,Kuntz KEvaluating Test Strategies for Colorectal Cancer Screening-Age to Begin, Age to Stop, and Timing of Screening Intervals: A Decision Analysis of Colorectal Cancer Screening for the U. S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET). Rockville, MD: Agency for Healthcare Research and Quality; 2009:.
43. van Rijn JC,Reitsma JB,Stoker J,Bossuyt PM,van Deventer SJ,Dekker E.Polyp miss rate determined by tandem colonoscopy: a systematic review.Am J Gastroenterol. 2006;101:343-350.
44. Barclay RL,Vicari JJ,Doughty AS,Johanson JF,Greenlaw RL.Colonoscopic withdrawal times and adenoma detection during screening colonoscopy.N Engl J Med. 2006;355:2533-2541.
45. Overholt BF,Brooks-Belli L,Grace M, et al.Withdrawal times and associated factors in colonoscopy: a quality assurance multicenter assessment.J Clin Gastroenterol. 2010;44:e80-e86.
46. Kaminski MF,Regula J,Kraszewska E, et al.Quality indicators for colonoscopy and the risk of interval cancer.N Engl J Med. 2010;362:1795-1803.
47. Lieberman D,Nadel M,Smith RA, et al.Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable.Gastrointest Endosc. 2007;65:757-766.
48. Rex DK,Petrini JL,Baron TH, et al.Quality indicators for colonoscopy.Am J Gastroenterol. 2006;101:873-885.
49. Gurudu SR,Heigh RI,De Petris G, et al.Sessile serrated adenomas: demographic, endoscopic and pathological characteristics.World J Gastroenterol. 2010;16:3402-3405.
50. Groff RJ,Nash R,Ahnen DJ.Significance of serrated polyps of the colon.Curr Gastroenterol Rep. 2008;10:490-498.
51. O'Brien MJ.Hyperplastic and serrated polyps of the colorectum.Gastroenterol Clin North Am. 2007;36:947-968.
52. Soetikno RM,Kaltenbach T,Rouse RV, et al.Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults.JAMA. 2008;299:1027-1035.
53. Lau PC,Sung JJ.Flat adenoma in colon: two decades of debate.J Dig Dis. 2010;11:201-207.
54. Zauber AG,O'Brien MJ,Winawer SJ.On finding flat adenomas: is the search worth the gain?.Gastroenterology. 2002;122:839-840.
55. Pickhardt PJ,Levin B,Bond JH.Screening for nonpolypoid colorectal neoplasms.JAMA. 2008 2743;299:.